ImmunoVec
Los Angeles, California, United States · Biotechnology, Therapeutics · 9 employees
ImmunoVec is a biotechnology company based in Los Angeles, CA, pioneering a novel approach to in vivo cell engineering. The company is developing therapies for autoimmune diseases, solid tumors, and genetic disorders using a proprietary platform that combines synthetic, cell type-specific promoters across multiple delivery vehicles. ImmunoVec aims to provide precise and durable expression of thera
Funding history
- Venture - Series Unknown — $12.7M — Jul 2026
- Grant — $40.7M — Oct 2025
Recent signals
- Jul 14, 2026: Raised $12.7M in Venture - Series Unknown
- Oct 08, 2025: Raised $40.7M in Grant
See plans & pricing → Track ImmunoVec’s funding, hiring, and signals — with verified contacts — on Fundz.